Medication Use
Trends in asthma medication use by patients in the TA-B-BAL and control
group are illustrated in Figure 3 . Four patients from the
TA-B-BAL group were able to discontinue all respiratory medications at
the time of the second post-operative visit. The average inhaled
corticosteroid (ICS) dose at initial assessment was higher in the
TA-B-BAL group (250.0mg) compared to the controls (100.0mg). Following
medical management, the average ICS dose in the TA-B-BAL group was
193.8mg. Post operatively, ICS dose in the TA-B-BAL group decreased to
150.0mg. At a time point matched with the TA-B-BAL group post-operative
visit, the controls average ICS dose was 210.4mg following standard
medical management of asthma (Figure 4 ).